South Korea

Latest Headlines

Latest Headlines

South Korea's Green Cross teams with Russia's Nanolek on biologics manufacturing

South Korea's Green Cross said it has signed an agreement with Nanolek, a Russia biopharmaceutical company, to produce its biologics in a three-month-old facility said to be state-of-the-art.

South Korea tells Bayer to divest oral contraceptives business

Bayer Korea has been ordered to divest its oral contraceptives business, chiefly its Mercilon (ethinylestradiol) drug, which it acquired when its Germany parent Bayer bought Merck's consumer-care business recently.

South Korea's Green Cross pushes into cell therapy manufacturing in China

South Korean bio pharma Green Cross will build a cell therapy manufacturing center in China's Guizhou province to distribute products in China.

Korea's Hanmi in deal with Kinex Pharma for India sales of Orascovery pump

Hanmi Pharmaceutical has signed a licensing agreement for Kinex Pharmaceuticals to develop its Orascovery pump inhibitor for gastrointestinal treatments in India.

Hanmi licenses poziotinib to U.S.-based Spectrum outside of China, South Korea

Hanmi Pharmaceutical has licensed its poziotinib for treating several types of cancer to U.S.-based Spectrum Pharmaceuticals.

South Korea pregnancy test kit and contraceptive sales firm up after adultery law struck down

Several South Korea drug and medical-device makers can expect to be the big winners from a Constitutional Court ruling striking down the nation's law making adultery a federal crime. The law was passed in 1953 to protect women.

Generic, biosimilar revenues look solid in Asia with many Indian firms eyeing innovation

Various recent reports covering the near-term and long-term outlook for the pharmaceutical industry in Asia paint a positive picture with increased revenues coming from the generics and biosimilars industries along with products as specific as human insulin from China.

Samsung BioLogics to expand new Songdo plant

South Korea's Samsung BioLogics has pledged to be a big deal in biosimilars, but so far its biologics subsidiary has produced mostly operating losses for its parent. In anticipation of turning that around, the company will undertake a significant expansion of the biologics plant in Songdo, Incheon, that it opened in 2013.

CrystalGenomics joins Daewoong to commercialize Acelex in South Korea

CrystalGenomics signed a sales and marketing deal with South Korea's Daewoong Pharmaceutical for the commercialization of Acelex (polmacoxib), granting the South Korean firm exclusive rights in country for the osteoarthritis treatment.

South Korea lifts ban on zilpaterol feed additives in beef

Almost a year after saying it would ease its policy on animal growth enhancers containing zilpaterol, the South Korean government lifted its ban on the feed additive. The move opens the door to beef imports and domestic sales of the product.